Šīs tīmekļa vietnes satura kvalitātes uzlabošanai un pielāgošanai lietotāju vajadzībām tiek lietotas sīkdatnes - tai skaitā arī trešo pušu sīkdatnes. Turpinot lietot šo vietni Jūs piekrītat sīkdatņu lietošanai.
Changes in the Management Team of JSC "Grindeks"
Emitents Grindeks, AS (5299006DWR32NKWM1O86)
Veids Būtiski notikumi
Valoda EN
Statuss Publicēts
Versija
Datums 2008-10-15 08:46:00
Versijas komentārs
Teksts

On the 13th of October 2008 Council of JSC Grindeks approved decision of the previous Member of the Board and Director of Business Unit of Active Pharmaceutical Ingredients Vitālijs Skrīvelis to return in applied science with focus on research of anti-cancer agents and biotechnological medications. Further Vitālijs Skrīvelis will be also operating as a Scientific Consultant of JSC Grindeks and the main responsibility of his activities will be supervision of research projects and implementation of innovative technologies.

In compliance with the decision of Council of JSC Grindeks Finance and Administrative Director Vadims Rabša has been elected as a Member of the Board of JSC Grindeks.

Andris Jegorovs, who previously was operating as Quality Director of JSC Olainfarm, has become Director of Business Unit of Active Pharmaceutical Ingredients of JSC Grindeks.

Sales and Marketing Director Armands Lapiņš, who previously was Marketing and Commercial Director of JSC Olainfarm, also joined the team of JSC Grindeks.

About Grindeks

JSC Grindeks is the leading pharmaceutical company in the Baltic States. Its main fields of action are: research, development and manufacturing of brand products, generics and active pharmaceutical ingredients. Grindeks specializes in the heart and cardiovascular, CNS and anti-cancer medication therapeutic groups.

A range of Grindeks’s products covers a successful combination of original products and generics, with the original products Mildronate® and Ftorafur® and more than 100 forms of effective and safe generics included therein.

Grindeks concern consists of four subsidiary companies in Latvia, Estonia and Russia, as well representatives and representative offices in fourteen countries. Products of the company are exported to more than 40 countries and its export comprises more than 96% of the total turnover. The main markets are: the Baltic States, Russia and other CIS countries, Japan, USA. Grindeks shares are listed in the Official List of Riga Stock Exchange. 

You are kindly invited to www.grindeks.lv to find out more about our company!

Contacts:
Laila Kļaviņa
Head of the Communications Department
JSC Grindeks
Phones: +371 67083370, + 371 29256012
e-mail: laila.klavina@grindeks.lv

 
Pielikumi
V_RabsaCV_ENGL.pdf (27.35 kB)
A_JegorovsCV_ENGL.pdf (6.57 kB)
A_LapinsCV_ENGL.pdf (15.09 kB)